Related Experiment Videos

Changes in the three-dimensional organization of LoVo cells associated with resistance to doxorubicin

C Soranzo1, A Ingrosso, M Buffa

  • 1Division of Experimental Oncology B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

Cancer Letters
|November 15, 1989
PubMed

Insights

Drug-resistant cancer cells showed impaired spheroid formation, independent of their resistance mechanism. This suggests spheroid growth is not linked to drug resistance pathways in these cell lines.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Drug Resistance

Background:

  • Spheroid culture systems are used to model tumor microenvironments.
  • Doxorubicin resistance in cancer cells can be mediated by various mechanisms.
  • Cellular morphology and growth patterns can be altered by drug resistance.

Purpose of the Study:

  • To investigate the relationship between doxorubicin resistance and spheroid formation in LoVo cells.
  • To determine if reversing drug resistance affects spheroid growth capacity.

Main Methods:

  • Comparison of LoVo cells and a doxorubicin-resistant subline in a 3D spheroid system.
  • Treatment of resistant cells with membrane-active agents to reverse pleiotropic drug resistance.

Main Results:

  • Doxorubicin-resistant LoVo cells failed to form spheroids, forming loose aggregates instead.
  • Agents that reversed pleiotropic drug resistance did not restore spheroid-forming ability in resistant cells.

Conclusions:

  • The inability of resistant cells to form spheroids is not directly linked to the drug resistance mechanism.
  • Spheroid formation capacity may be influenced by factors independent of common drug resistance pathways.

Related Concept Videos